The potential therapeutic efficacy of lactobacillus GG in children with food allergies

Pharmaceuticals

Volumn 5, Issue 6, 2012, Pages 655-664

  Canani, Roberto Berni ^a   Di Costanzo, Margherita ^a   Pezzella, Vincenza ^a   Cosenza, Linda ^a   Granata, Viviana ^a   Terrin, Gianluca ^b   Nocerino, Rita ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Atopic march; Cow's milk allergy; Food allergy; Immune system; Infants; Intestinal microflora; Lactobacillus GG; Pediatrics; Probiotic; Tolerance acquisition

Indexed keywords

FOOD ALLERGEN; PLACEBO; PROBIOTIC AGENT;

ARTIFICIAL MILK; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FOOD ALLERGY; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INTESTINE CELL; INTESTINE FLORA; INTESTINE FUNCTION DISORDER; LACTOBACILLUS; MILK ALLERGY; NONHUMAN; PATHOGENESIS; PROGNOSIS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW;

EID: 84863618880     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph5060655     Document Type: Review

References (39)

1. Allen, K.J.; Koplin, J.J. The epidemiology of IgE-mediated food allergy and anaphylaxis Immun. Allergy Clin. North Am. 2012, 32, 35-50.
2. Apps, J.R.; Beattie, R.M. Cow's milk allergy in children. Cont. Med. Educ. 2009, 339, b2275.
3. Høst, A.; Halken, S.; Jacobsen, HP.; Christensen, A.E.; Herskind, A.M.; Plesner, K. Clinical course of cow's milk protein allergy/intolerance and atopic diseases in childhood. Pediatr. Allergy Immun. 2002, 13, 23-28.
4. Skripak, J.M.; Matsui, E.C.; Mudd, K.; Wood, R.A. The natural history of IgE-mediated cow's milk allergy. J Allergy Clin. Immun. 2007, 120, 1172-1177.
5. Levy, Y.; Segal, N.; Garty, B.; Danon, Y.L. Lessons from the clinical course of IgE-mediated cow milk allergy in Israel. Pediatr. Allergy Immun. 2007, 18, 589-593.
6. Kneepkens, C.M.; Meijer, Y. Clinical practice. Diagnosis and treatment of cow's milk allergy. Eur. J. Pediatr. 2009, 168, 891-896.
7. Özdemir, Ö. Various effects of different probiotic strains in allergic disorders: An update from laboratory and clinical data. Clin. Exp. Immun. 2010, 160, 295-304.
8. Özdemir, Ö. Gut flora development in infancy and its effect on immune system (in Turkish). Çocuk Enf. Derg. (J. Pediatr. Inf.) 2009, 3, 202-203.
9. Agheyisi, R. The Probiotics Market: Ingredients, Supplements, Foods. BCC Research. Report: FOD013D. Available online: http://www.bccresearch.com/report/nutraceuticals-marketsprocessing-technologies-fod013d.html (accessed on 18 June 2012).
10. Yan, F.; Polk, D.B. Probiotics: progress toward novel therapies for intestinal diseases. Curr. Opin. Gastroenterol. 2010, 26, 95-101.
11. Björkstén, B.; Sepp, E.; Julge, K.; Voor, T.; Mikelsaar, M. Allergy developmentand the intestinal microflora during the first year of life. J. Allergy Clin. Immun. 2001, 108, 516-520.
12. Harmsen, H.J.; Wildeboer-Veloo, A.C.; Raangs, G.C.; Wagendorp, A.A.; Klijn, N.; Bindels, J.G.; Welling, G.W. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J. Pediatr. Gastr. Nutr. 2000, 30, 61-67.
13. Kalliomaki, M.; Kirjavainen, P.; Eerola, E.; Kero, P.; Salminen, S.; Isolauri, E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immun. 2001, 107, 129-134.
14. Sherman, P.M.; Ossa, J.C.; Johnson-Henry, K. Unraveling Mechanisms of Action of Probiotics. Nutr. Clin. Pract. 2009, 24, 10.
15. Sütas, Y.; Soppi, E.; Korhonen, H.; Syväoja, E.L.; Saxelin, M.; Rokka, T.; Isolauri, E. Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolyzed with Lactobacillus casei GG-derived enzymes. J. Allergy Clin. Immu. 1996, 98, 216-224.
16. Yan, F.; Cao, H.; Cover, T.L.; Washington, M.K.; Polk, D.B. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007, 132, 562-575.
17. Gourbeyre, P.; Denery, S.; Bodinier, M. Probiotics, prebiotics, and synbiotics: Impact on the gut immune system and allergic reactions. J. Leukoc. Biol. 2011, 89, 685-695.
18. Berni Canani, R.; Di Costanzo, M.; Leone, L.; Bedogni, G.; Brambilla, P. K; Cianfarani, S.; Nobili, V. M; Pietrobelli, A.; Agostoni, C. Epigenetic mechanisms elicited by nutrition in early life. Nutr. Res. Rev. 2011, 24, 198-205.
19. Berni Canani, R.; Di Costanzo, M.; Leone, L. The epigenetic effects of butyrate: Potential therapeutic implications for clinical practice. Clin. Epigenetics 2012, 4, 4.
20. Mowat, A.M. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immun. 2003, 3, 331-341.
21. Vighi, G.; Marcucci, F.; Sensi, L.; Di Cara, G.; Frati, F. Allergy and the gastrointestinal system. Clin. Exp. Immun. 2008, 153, 3-6.
22. Romagnani, S. Regulation of the development of type 2 T-helper cells in allergy. Curr. Opin. Immun. 1994, 6, 838-846.
23. Sudo, N.; Sawamura, S.A.; Tanaka, K.; Aiba, Y.; Kubo, C.; Koga, Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immun. 1997, 159, 1739-1745.
24. Rodriguez, B.; Prioult, G.; Hacini-Rachinel, F.; Moine, D.; Bruttin, A.; Ngom-Bru, C.; Labellie, C.; Nicolis, I.; Berger, B.; Mercenier, A. Infant gut microbiota is protective against cow's milk allergy in mice despite immature ileal T-cell response. FEMS Microbiol. Ecol. 2011, 79, 192-202.
25. Kalliomaki, M.; Antoine, J.M.; Herz, U.; Rijkers, G.T.; Wells, J.M.; Mercenier, A. Guidance for substantiating the evidence for beneficial effects of probiotics: Prevention and management of allergic diseases by probiotics. J. Nutr. 2010, 140, 713S-721S.
26. Berni Canani, R.; Ruotolo, S.; Discepolo, V.; Troncone, R. The diagnosis of food allergy in children. Curr. Opin. Pediatr. 2008, 20, 584-589.
27. Majamaa, H.; Isolauri, E. Probiotics: A novel approach in the management of food allergy. J. Allergy Clin. Immun. 1997, 99, 179-185.
28. Isolauri, E.; Arvola, T.; Sutas, Y.; Moilanen, E.; Salminen, S. Probiotics in the management of atopic eczema. Clin. Exp. Allergy 2000, 30, 1604-1610.
29. Isolauri, E. Studies on Lactobacillus GG in food hypersensitivity disorders. Nutr. Today Suppl. 1996, 31, 285-315.
30. Nermes, M.; Kantele, J.M.; Atosuo, T.J.; Salminen, S.; Isolauri, E. Interaction of orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis. Clin. Exp. Allergy 2010, 41, 370-377.
31. Pohjavuori, E.; Viljanen, M.; Korpela, R.; Kuitunen, M.; Tiittanen, M.; Vaarala, O.; Savilahti, E. Lactobacillus GG effect in increasing IFN-γ production in infants with cow's milk allergy. J. Allergy Clin. Immun. 2004, 114, 131-136.
32. Baldassarre, M.E.; Laforgia, N.; Fanelli, M.; Laneve, A.; Grosso, R.; Lifschitz, C. Lactobacillus GG improves recovery in infants with blood in the stools and presumptive allergic colitis compared with extensively hydrolyzed formula alone. J. Pediatr. 2010, 156, 397-401.
33. Hol, J.; van Leer, E.H.; Elink Schuurman, B.E.; de Ruiter, L.F.; Samsom, J.N.; Hop, W.; Neijens, H.J.; de Jongste, J.C.; Nieuwenhuis, E.E. Cow's Milk Allergy Modified by Elimination and Lactobacilli study group. The acquisition of tolerance toward cow's milk through probiotic supplementation: A randomized, controlled trial. J. Allergy Clin. Immun. 2008, 121, 1448-1454.
34. Canani, R.B.; Nocerino, R.; Terrin, G.; Coruzzo, A.; Cosenza, L.; Leone, L.; Troncone, R. Effect of extensively hydrolyzed casein formula supplemented with Lactobacillus GG on tolerance acquisition in infants with cow's milk allergy: A randomized trial. J. Allergy Clin. Immun. 2012, 129, 580-582.
35. Gordon, B.R. The allergic march: Can we prevent allergies and asthma? Otolaryngol Clin. North Am. 2011, 44, 765-77.
36. Saps, M.; Lu, P.; Bonilla, S. Cow's-milk allergy is a risk factor for the development of FGIDs in children. J. Ped. Gastroenterol Nutr. 2011, 52, 166-169.
37. Rousseaux, C.; Thuru, X.; Gelot, A.; Barnich, N.; Neut, C.; Dubuquoy, L.; Dubuquoy, C.; Merour, E.; Geboes, K.; Chamaillard, M.; et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat. Med. 2007, 13, 35-37.
38. Gawrońska, A.; Dziechciarz, P.; Horvath, A.; Szajewska, H. A randomized double blind placebo controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharm. Ther. 2007, 25, 177-184.
39. Muraro, A.; Hoekstra, M.O.; Meijer, Y.; Lifschitz, C.; Wampler, J.L.; Harris, C.; Scalabrin, D.M. Extensively hydrolysed casein formula supplemented with Lactobacillus rhamnosus GG maintains hypoallergenic status: Randomised double-blind, placebo-controlled crossover trial. BMJ Open 2012, 5, 2.